Interspecies differences in metabolism of arsenic by cultured primary hepatocytes.

Department of Nutrition, University of North Carolina, Chapel Hill, NC 27599-7461, USA.
Toxicology and Applied Pharmacology (Impact Factor: 3.98). 02/2010; 245(1):47-56. DOI: 10.1016/j.taap.2010.01.015
Source: PubMed

ABSTRACT Biomethylation is the major pathway for the metabolism of inorganic arsenic (iAs) in many mammalian species, including the human. However, significant interspecies differences have been reported in the rate of in vivo metabolism of iAs and in yields of iAs metabolites found in urine. Liver is considered the primary site for the methylation of iAs and arsenic (+3 oxidation state) methyltransferase (As3mt) is the key enzyme in this pathway. Thus, the As3mt-catalyzed methylation of iAs in the liver determines in part the rate and the pattern of iAs metabolism in various species. We examined kinetics and concentration-response patterns for iAs methylation by cultured primary hepatocytes derived from human, rat, mice, dog, rabbit, and rhesus monkey. Hepatocytes were exposed to [(73)As]arsenite (iAs(III); 0.3, 0.9, 3.0, 9.0 or 30 nmol As/mg protein) for 24 h and radiolabeled metabolites were analyzed in cells and culture media. Hepatocytes from all six species methylated iAs(III) to methylarsenic (MAs) and dimethylarsenic (DMAs). Notably, dog, rat and monkey hepatocytes were considerably more efficient methylators of iAs(III) than mouse, rabbit or human hepatocytes. The low efficiency of mouse, rabbit and human hepatocytes to methylate iAs(III) was associated with inhibition of DMAs production by moderate concentrations of iAs(III) and with retention of iAs and MAs in cells. No significant correlations were found between the rate of iAs methylation and the thioredoxin reductase activity or glutathione concentration, two factors that modulate the activity of recombinant As3mt. No associations between the rates of iAs methylation and As3mt protein structures were found for the six species examined. Immunoblot analyses indicate that the superior arsenic methylation capacities of dog, rat and monkey hepatocytes examined in this study may be associated with a higher As3mt expression. However, factors other than As3mt expression may also contribute to the interspecies differences in the hepatocyte capacity to methylate iAs.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the dose-response relationship between arsenic (As) exposure and markers of oxidative damage in Bangladeshi adults.
    Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 05/2014; · 1.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hundreds of millions of people world-wide are exposed to unacceptable levels of arsenic in drinking water. This is a public health crisis because arsenic is a Group I (proven) human carcinogen. Human cells methylate arsenic to monomethylarsonous acid (MMA(III)), monomethylarsonic acid (MMA(V)), dimethylarsinous acid (DMA(III)), and dimethylarsinic acid (DMA(V)). Although the liver is the predominant site for arsenic methylation, elimination occurs mostly in urine. The protein(s) responsible for transport of arsenic from the liver (into blood), ultimately for urinary elimination are unknown. Human multidrug resistance protein 1 (MRP1/ABCC1) and MRP2 (ABCC2), are established arsenic efflux pumps, but unlike the related MRP4 (ABCC4), are not present at the basolateral membrane of hepatocytes. MRP4 is also found at the apical membrane of renal proximal tubule cells making it an ideal candidate for urinary arsenic elimination. In the current study, human MRP4 expressed in HEK293 cells reduced the cytotoxicity and cellular accumulation of As(V), MMA(III), MMA(V), DMA(III), and DMA(V) while two other hepatic basolateral MRPs (MRP3 and MRP5) did not. Transport studies with MRP4-enriched membrane vesicles revealed that the diglutathione conjugate of MMA(III) [MMA(GS)2] and DMA(V) were the transported species. MMA(GS)2 and DMA(V) transport was osmotically sensitive, allosteric (Hill coefficients of 1.4 ± 0.2 and 2.9 ± 1.2, respectively), and high affinity (K0.5 of 0.70 ± 0.16 μM and 0.22 ± 0.15 μM, respectively). DMA(V) transport was pH dependent with highest affinity and capacity at pH 5.5. These results suggest human MRP4 could be a major player in the elimination of arsenic.
    Molecular pharmacology. 05/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: The rhesus monkey liver disease model provides useful information for hepatic research, as studies of hepatic hemodynamics in humans are rare. A 3-9 MHz high-frequency linear transducer (iU22, Philips Medical Systems, Royal Philips Electronics, The Netherlands) was used to obtain ultrasonograms of the livers of 28 normal rhesus monkeys (16 males, 12 females). Diameters of the portal vein and proper hepatic artery; maximum velocity of the portal vein; and peak-systolic and end-diastolic velocity and resistive index of the proper hepatic artery were also assessed. The portal vein and proper hepatic artery were 0.584 ± 0.123 and 0.151 ± 0.052 cm in diameter, respectively. The maximum velocity of the portal vein was 40.2 ± 13.7 cm/s. Peak systolic velocity and resistive index of the proper hepatic artery were 72.2 ± 25.4 cm/s and 0.67 ± 0.10, respectively. We found that high-frequency Doppler ultrasonography can be used to obtain clear portal vein and proper hepatic artery ultrasonograms and to measure the hemodynamic parameters of the portal vein and proper hepatic artery in rhesus monkeys. It is thus an effective method for studying changes in hepatic hemodynamics and has interesting technical and therapeutic implications. Our results provide useful information and establish normal reference values for future studies of adult healthy rhesus monkeys.
    Ultrasound in medicine & biology 01/2014; · 2.46 Impact Factor

Full-text (2 Sources)

Available from
Oct 17, 2014